Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WIGLEY, Fredrick")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 55

  • Page / 3
Export

Selection :

  • and

Raynaud's phenomenonWIGLEY, Fredrick M.The New England journal of medicine. 2002, Vol 347, Num 13, pp 1001-1008, issn 0028-4793Article

Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosisCLOWSE, Megan E. B; WIGLEY, Fredrick M.Journal of rheumatology. 2003, Vol 30, Num 6, pp 1341-1343, issn 0315-162X, 3 p.Article

Management of Raynaud's phenomenon and digital ischemic lesions in sclerodermaHUMMERS, Laura K; WIGLEY, Fredrick M.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, issn 0889-857X, vi, 293-313 [16 p.]Article

Telangiectases in Scleroderma: A Potential Clinical Marker of Pulmonary Arterial HypertensionSHAH, Ami A; WIGLEY, Fredrick M; HUMMERS, Laura K et al.Journal of rheumatology. 2010, Vol 37, Num 1, pp 98-104, issn 0315-162X, 7 p.Article

Scleroderma patients with combined pulmonary hypertension and interstitial lung diseaseCHANG, Betty; WIGLEY, Fredrick M; WHITE, Barbara et al.Journal of rheumatology. 2003, Vol 30, Num 11, pp 2398-2405, issn 0315-162X, 8 p.Article

Abnormalities in the Regulators of Angiogenesis in Patients with SclerodermaHUMMERS, Laura K; HALL, Amy; WIGLEY, Fredrick M et al.Journal of rheumatology. 2009, Vol 36, Num 3, pp 576-582, issn 0315-162X, 7 p.Article

Still Ill?WUNG, Peter K; PIPELING, Matthew R; WIGLEY, Fredrick M et al.The American journal of medicine. 2008, Vol 121, Num 6, pp 491-493, issn 0002-9343, 3 p.Article

Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma : A different kind of renal crisisKAMEN, Diane L; WIGLEY, Fredrick M; BROWN, Alan N et al.Journal of rheumatology. 2006, Vol 33, Num 9, pp 1886-1888, issn 0315-162X, 3 p.Article

Thoracic Outlet Syndrome Secondary to Localized Scleroderma Treated With Botulinum Toxin InjectionLE, Elizabeth N; FREISCHLAG, Julie A; CHRISTO, Paul J et al.Arthritis care and research. 2010, Vol 62, Num 3, pp 430-433, issn 0893-7524, 4 p.Article

Close Temporal Relationship Between Onset of Cancer and Scleroderma in Patients With RNA Polymerase I/III AntibodiesSHAH, Ami A; ROSEN, Antony; HUMMERS, Laura et al.Arthritis and rheumatism. 2010, Vol 62, Num 9, pp 2787-2795, issn 0004-3591, 9 p.Article

Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertensionULANET, Danielle B; WIGLEY, Fredrick M; GELBER, Allan C et al.Arthritis care and research. 2003, Vol 49, Num 1, pp 85-92, issn 0893-7524, 8 p.Article

A deceptive case of amyloid myopathy : Clinical and magnetic resonance imaging featuresHULL, Keith M; GRIFFITH, Lawrence; KUNCL, Ralph W et al.Arthritis and rheumatism. 2001, Vol 44, Num 8, pp 1954-1958, issn 0004-3591Article

Late-age Onset Systemic SclerosisMANNO, Rebecca L; WIGLEY, Fredrick M; GELBER, Allan C et al.Journal of rheumatology. 2011, Vol 38, Num 7, pp 1317-1325, issn 0315-162X, 9 p.Article

Persistence of Abnormal Bronchoalveolar Lavage Findings After Cyclophosphamide Treatment in Scleroderma Patients With Interstitial Lung DiseaseMITTOO, Shikha; WIGLEY, Fredrick M; WISE, Robert et al.Arthritis and rheumatism. 2007, Vol 56, Num 12, pp 4195-4202, issn 0004-3591, 8 p.Article

Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in sclerodermaCHANG, Betty; SCHACHNA, Lionel; WHITE, Barbara et al.Journal of rheumatology. 2006, Vol 33, Num 2, pp 269-274, issn 0315-162X, 6 p.Article

T Cell Polarization Identifies Distinct Clinical Phenotypes in Scleroderma Lung DiseaseBOIN, Francesco; DE FANIS, Umberto; BARTLETT, Susan J et al.Arthritis and rheumatism. 2008, Vol 58, Num 4, pp 1165-1174, issn 0004-3591, 10 p.Article

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosisLE, Elizabeth N; WIGLEY, Fredrick M; SHAH, Ami A et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 6, pp 1104-1107, issn 0003-4967, 4 p.Article

The association of body image dissatisfaction and pain with reduced sexual function in women with systemic sclerosisKNAFO, Ruby; HAYTHORNTHWAITE, Jennifer A; HEINBERG, Leslie et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 6, pp 1125-1130, issn 1462-0324, 6 p.Article

Independent Association of Anti-β2-Glycoprotein I Antibodies With Macrovascular Disease and Mortality in Scleroderma PatientsBOIN, Francesco; FRANCHINI, Stefano; COLANTUONI, Elizabeth et al.Arthritis and rheumatism. 2009, Vol 60, Num 8, pp 2480-2489, issn 0004-3591, 10 p.Article

Predictors and outcomes of scleroderma renal crisis: The high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trialDEMARCO, Paul J; WEISMAN, Michael H; MORELAND, Larry et al.Arthritis and rheumatism. 2002, Vol 46, Num 11, pp 2983-2989, issn 0004-3591, 7 p.Article

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease : Results from the scleroderma lung studyKHANNA, Dinesh; XIAOHONG YAN; RILEY, David J et al.Arthritis and rheumatism. 2007, Vol 56, Num 5, pp 1676-1684, issn 0004-3591, 9 p.Article

The Disability Index of the health assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trialCLEMENTS, Philip J; WENG KEE WONG; MEDSGER, Thomas A et al.Arthritis and rheumatism. 2001, Vol 44, Num 3, pp 653-661, issn 0004-3591Article

Clinical differences between idiopathic and scleroderma-related pulmonary hypertensionFISHER, Micah R; MATHAI, Stephen C; CHAMPION, Hunter C et al.Arthritis and rheumatism. 2006, Vol 54, Num 9, pp 3043-3050, issn 0004-3591, 8 p.Article

High-dose versus low-dose d-penicillamine in early diffuse systemic sclerosis trial: Lessons learnedCLEMENTS, Philip J; SEIBOLD, James R; STEEN, Virginia et al.Seminars in arthritis and rheumatism. 2004, Vol 33, Num 4, pp 249-263, issn 0049-0172, 15 p.Article

Lack of Detection of Agonist Activity by Antibodies to Platelet-Derived Growth Factor Receptor a in a Subset of Normal and Systemic Sclerosis Patient SeraLOIZOS, Nick; LARICCIA, Leah; WEINER, Jami et al.Arthritis and rheumatism. 2009, Vol 60, Num 4, pp 1145-1151, issn 0004-3591, 7 p.Article

  • Page / 3